131 related articles for article (PubMed ID: 19275588)
1. Structure-function relationship of Vpr: biological implications.
Morellet N; Roques BP; Bouaziz S
Curr HIV Res; 2009 Mar; 7(2):184-210. PubMed ID: 19275588
[TBL] [Abstract][Full Text] [Related]
2. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.
Jacquot G; Le Rouzic E; David A; Mazzolini J; Bouchet J; Bouaziz S; Niedergang F; Pancino G; Benichou S
Retrovirology; 2007 Nov; 4():84. PubMed ID: 18039376
[TBL] [Abstract][Full Text] [Related]
3. Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1.
Kino T; Pavlakis GN
DNA Cell Biol; 2004 Apr; 23(4):193-205. PubMed ID: 15142377
[TBL] [Abstract][Full Text] [Related]
4. Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.
Barnitz RA; Chaigne-Delalande B; Bolton DL; Lenardo MJ
PLoS One; 2011; 6(9):e24924. PubMed ID: 21949789
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr: a closer look at the multifunctional protein from the structural perspective.
Pandey RC; Datta D; Mukerjee R; Srinivasan A; Mahalingam S; Sawaya BE
Curr HIV Res; 2009 Mar; 7(2):114-28. PubMed ID: 19275580
[TBL] [Abstract][Full Text] [Related]
6. The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.
Wen X; Casey Klockow L; Nekorchuk M; Sharifi HJ; de Noronha CM
PLoS One; 2012; 7(1):e30939. PubMed ID: 22292079
[TBL] [Abstract][Full Text] [Related]
7. Structure of HIV-1 Vpr in complex with the human nucleotide excision repair protein hHR23A.
Byeon IL; Calero G; Wu Y; Byeon CH; Jung J; DeLucia M; Zhou X; Weiss S; Ahn J; Hao C; Skowronski J; Gronenborn AM
Nat Commun; 2021 Nov; 12(1):6864. PubMed ID: 34824204
[TBL] [Abstract][Full Text] [Related]
8. Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.
Singh SP; Tomkowicz B; Lai D; Cartas M; Mahalingam S; Kalyanaraman VS; Murali R; Srinivasan A
J Virol; 2000 Nov; 74(22):10650-7. PubMed ID: 11044109
[TBL] [Abstract][Full Text] [Related]
9. Murine models of Vpr-mediated pathogenesis.
Snyder A; Ross MJ
Curr HIV Res; 2009 Mar; 7(2):129-35. PubMed ID: 19275581
[TBL] [Abstract][Full Text] [Related]
10. Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 Vpr.
Wallet C; Rohr O; Schwartz C
Biochem Pharmacol; 2020 Oct; 180():114128. PubMed ID: 32619426
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.
Li G; Park HU; Liang D; Zhao RY
Retrovirology; 2010 Jul; 7():59. PubMed ID: 20609246
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.
Zhu Y; Gelbard HA; Roshal M; Pursell S; Jamieson BD; Planelles V
J Virol; 2001 Apr; 75(8):3791-801. PubMed ID: 11264368
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr).
Majumder B; Venkatachari NJ; Srinivasan A; Ayyavoo V
Curr HIV Res; 2009 Mar; 7(2):169-77. PubMed ID: 19275586
[TBL] [Abstract][Full Text] [Related]
14. Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
Cassiday PA; DePaula-Silva AB; Chumley J; Ward J; Barker E; Planelles V
Virology; 2015 Feb; 476():19-25. PubMed ID: 25499532
[TBL] [Abstract][Full Text] [Related]
15. Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.
Fritz JV; Didier P; Clamme JP; Schaub E; Muriaux D; Cabanne C; Morellet N; Bouaziz S; Darlix JL; Mély Y; de Rocquigny H
Retrovirology; 2008 Sep; 5():87. PubMed ID: 18808682
[TBL] [Abstract][Full Text] [Related]
16. HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.
Soares R; Rocha G; Meliço-Silvestre A; Gonçalves T
Rev Med Virol; 2016 Sep; 26(5):314-29. PubMed ID: 27264019
[TBL] [Abstract][Full Text] [Related]
17. Vpr and its interactions with cellular proteins.
Planelles V; Benichou S
Curr Top Microbiol Immunol; 2009; 339():177-200. PubMed ID: 20012529
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vpr suppresses the cytomegalovirus promoter in a CRL4(DCAF1) E3 ligase independent manner.
Liu X; Guo H; Wang H; Markham R; Wei W; Yu XF
Biochem Biophys Res Commun; 2015 Apr; 459(2):214-219. PubMed ID: 25704090
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.
Chen M; Elder RT; Yu M; O'Gorman MG; Selig L; Benarous R; Yamamoto A; Zhao Y
J Virol; 1999 Apr; 73(4):3236-45. PubMed ID: 10074177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
